Financial results - ORION BIOLOGICS SRL

Financial Summary - Orion Biologics Srl
Unique identification code: 31508158
Registration number: J12/1205/2013
Nace: 4646
Sales - Ron
118.226
Net Profit - Ron
25.778
Employees
2
Open Account
Company Orion Biologics Srl with Fiscal Code 31508158 recorded a turnover of 2024 of 118.226, with a net profit of 25.778 and having an average number of employees of 2. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Orion Biologics Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 175.962 168.953 186.224 156.110 202.227 180.902 303.439 242.074 162.332 118.226
Total Income - EUR 176.497 169.413 186.553 156.599 202.589 181.865 304.867 244.291 173.274 131.284
Total Expenses - EUR 152.394 142.383 160.401 138.779 155.483 151.104 204.141 168.279 128.745 102.691
Gross Profit/Loss - EUR 24.102 27.030 26.153 17.820 47.106 30.761 100.726 76.012 44.528 28.593
Net Profit/Loss - EUR 20.126 22.547 24.290 16.259 45.084 29.045 98.056 73.954 43.065 25.778
Employees 3 3 3 3 3 3 3 3 3 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -26.8%, from 162.332 euro in the year 2023, to 118.226 euro in 2024. The Net Profit decreased by -17.046 euro, from 43.065 euro in 2023, to 25.778 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Orion Biologics Srl

Rating financiar

Financial Rating -
ORION BIOLOGICS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Orion Biologics Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Orion Biologics Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Orion Biologics Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Orion Biologics Srl - CUI 31508158

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.101 692 1.919 1.103 723 382 332 291 248 205
Current Assets 51.626 46.687 48.354 33.191 74.745 96.603 181.790 206.302 238.077 262.594
Inventories 424 9 991 973 954 3.352 3.853 3.865 6.608 3.088
Receivables 5.721 982 33.177 12.474 10.939 6.552 2.530 8.519 3.160 5.425
Cash 45.481 45.696 14.185 19.744 62.851 86.698 175.408 193.918 228.310 254.082
Shareholders Funds 31.996 34.295 35.851 27.814 61.485 78.408 163.606 184.705 227.210 251.718
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 20.732 13.094 14.424 6.496 14.070 18.685 18.586 21.981 11.173 11.162
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 262.594 euro in 2024 which includes Inventories of 3.088 euro, Receivables of 5.425 euro and cash availability of 254.082 euro.
The company's Equity was valued at 251.718 euro, while total Liabilities amounted to 11.162 euro. Equity increased by 25.778 euro, from 227.210 euro in 2023, to 251.718 in 2024.

Risk Reports Prices

Reviews - Orion Biologics Srl

Comments - Orion Biologics Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.